Candidiasis
Safa DÖNMEZ
University of Health Sciences Faculty of Medicine, Ankara City Hospital, Department of Emergency Medicine, Ankara, Türkiye
Dönmez S. Candidiasis. In: Oğuztürk H, Görmeli Kurt N, eds. Dermatologic Emergencies. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.91-5.
ABSTRACT Candidiasis is a prevalent fungal infection commonly associated with C. albicans. While candida species are normally part of the human body’s natural flora, they can cause infections in individuals with weakened immune systems. In the United States, candida species are among the leading causes of hospital-acquired infections, with C. albicans being the most frequently encountered species. Other significant species include C. glabrata, C. parapsilosis, and C. auris. Candidiasis can present in a wide spectrum, ranging from superficial mucocutaneous infections to severe invasive disease associated with candidemia. Clinically, it manifests in various forms including oral candidiasis, gastrointestinal candidiasis, dermatological infections, vaginal and penile candidiasis, and invasive candidiasis. Oral candidiasis is typically characterized by white plaques, whereas gastrointestinal candidiasis often presents with odynophagia and dysphagia. Dermatological infections are commonly marked by erythema and white plaques. Diagnosis is generally established through microscopy and culture methods, with advanced techniques such as blood cultures and PCR employed for systemic candidiasis. Treatment depends on the severity and type of infection and is managed with antifungal agents. Mild cases are often controlled with topical treatments, while systemic infections require intravenous antifungal therapy. Complications such as prosthetic stomatitis and angular cheilitis necessitate appropriate treatment and hygiene measures.
Keywords: Candida albicans; candidiasis; oral candidiasis; invasive candidiasis; antifungal agents
Kaynak Göster
Referanslar
- Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics (Basel). 2020;9(6):312. [Crossref] [PubMed] [PMC]
- Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133-63. [Crossref] [PubMed] [PMC]
- Metin A, Dilek N, Bilgili SG. Recurrent candidal intertrigo: challenges and solutions. Clin Cosmet Investig Dermatol. 2018;11:175-85. [Crossref] [PubMed] [PMC]
- Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95-105. [Crossref] [PubMed] [PMC]
- Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol. 1994;31(3 Pt 2):S2-S5. [Crossref] [PubMed]
- R AN, Rafiq NB. Candidiasis. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. [PubMed]
- Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, et al. Candida albicans-The virulence Factors and Clinical Manifestations of Infection. J Fungi (Basel). 2021;7(2):79. [Crossref] [PubMed] [PMC]
- Valente P, Ferreira J, Pinto I, Medeiros N, Oliveira P, Castro E, et al. Management of laryngeal candidiasis: an evidence-based approach for the otolaryngologist. Eur Arch Otorhinolaryngol. 2020;277(5):1267-72. [Crossref] [PubMed]
- Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics (Basel). 2022;11(6):718. [Crossref] [PubMed] [PMC]
- Fang J, Huang B, Ding Z. Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis. J Prosthet Dent. 2021;125(2):257-65. [Crossref] [PubMed]
- Zhang Z, Zhang X, Zhou YY, Jiang CM, Jiang HY. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. BJOG. 2019;126(13):1546-52. [Crossref] [PubMed]
- Nirmala M, Smitha SG, Kamath GJ. A Study to Assess The Efficacy of Local Application of Oral Probiotic in Treating Recurrent Aphthous Ulcer and Oral Candidiasis. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 1):113-7. [Crossref] [PubMed] [PMC]